Dreigende vroeggeboorte

Initiatief: NVOG Aantal modules: 25

Magnesiumsulfaat bij dreigende vroeggeboorte

De module 'Magnesiumsulfaat bij dreigende vroeggeboorte' bestaat uit de volgende submodules:

  • Magnesiumsulfaat tussen de 24 en 34 weken
  • Magnesiumsulfaat onder de 30 weken
  • Magnesiumsulfaat boven de 30 weken

Onderbouwing

  1. Chollat C, Enser M, Houivet E, Provost D, Bénichou J, Marpeau L, Marret S. School-age outcomes following a randomized controlled trial of magnesium sulfate for neuroprotection of preterm infants. J Pediatr. 2014 Aug;165(2):398-400.e3. doi: 10.1016/j.jpeds.2014.04.007. Epub 2014 May 14. PMID: 24837863.
  2. Crowther CA, Hiller JE, Doyle LW, Haslam RR; Australasian Collaborative Trial of Magnesium Sulphate (ACTOMg SO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA. 2003 Nov 26;290(20):2669-76. doi: 10.1001/jama.290.20.2669. PMID: 14645308.
  3. Crowther CA, Middleton PF, Voysey M, Askie L, Duley L, Pryde PG, Marret S, Doyle LW; AMICABLE Group. Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis. PLoS Med. 2017 Oct 4;14(10):e1002398. doi: 10.1371/journal.pmed.1002398. PMID: 28976987; PMCID: PMC5627896.
  4. Crowther CA, Ashwood P, Middleton PF, McPhee A, Tran T, Harding JE; MAGENTA Study Group. Prenatal Intravenous Magnesium at 30-34 Weeks' Gestation and Neurodevelopmental Outcomes in Offspring: The MAGENTA Randomized Clinical Trial. JAMA. 2023 Aug 15;330(7):603-614. doi: 10.1001/jama.2023.12357. PMID: 37581672; PMCID: PMC10427942.
  5. Doyle LW, Anderson PJ, Haslam R, Lee KJ, Crowther C; Australasian Collaborative Trial of Magnesium Sulphate (ACTOMgSO4) Study Group. School-age outcomes of very preterm infants after antenatal treatment with magnesium sulfate vs placebo. JAMA. 2014 Sep 17;312(11):1105-13. doi: 10.1001/jama.2014.11189. PMID: 25226476.
  6. Marret S, Marpeau L, Zupan-Simunek V, Eurin D, Lévêque C, Hellot MF, Bénichou J; PREMAG trial group. Magnesium sulphate given before very-preterm birth to protect infant brain: the randomised controlled PREMAG trial*. BJOG. 2007 Mar;114(3):310-8. doi: 10.1111/j.1471-0528.2006.01162.x. Epub 2006 Dec 4. PMID: 17169012.
  7. Mittendorf R, Pryde PG, Lee KS. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol. 2003 Aug;189(2):613. doi: 10.1067/s0002-9378(03)00475-7. PMID: 14524362.
  8. Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM, Iams JD, Wapner RJ, Sorokin Y, Alexander JM, Harper M, Thorp JM Jr, Ramin SM, Malone FD, Carpenter M, Miodovnik M, Moawad A, O'Sullivan MJ, Peaceman AM, Hankins GD, Langer O, Caritis SN, Roberts JM; Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. N Engl J Med. 2008 Aug 28;359(9):895-905. doi: 10.1056/NEJMoa0801187. PMID: 18753646; PMCID: PMC2803083.
  9. Shepherd ES, Goldsmith S, Doyle LW, Middleton P, Marret S, Rouse DJ, Pryde P, Wolf HT, Crowther CA. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2024 May 10;5(5):CD004661. doi: 10.1002/14651858.CD004661.pub4. PMID: 38726883; PMCID: PMC11082932.
  10. Wolf HT, Brok J, Henriksen TB, Greisen G, Salvig JD, Pryds O, Hedegaard M, Weber T, Hegaard HK, Pinborg A, Huusom LD; MASP research group. Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double-blind, randomised, placebo-controlled, multi-centre trial. BJOG. 2020 Sep;127(10):1217-1225. doi: 10.1111/1471-0528.16239. Epub 2020 Apr 29. PMID: 32237024.
  11. Wolf HT, Huusom LD, Henriksen TB, Hegaard HK, Brok J, Pinborg A. Magnesium sulphate for fetal neuroprotection at imminent risk for preterm delivery: a systematic review with meta-analysis and trial sequential analysis. BJOG. 2020 Sep;127(10):1180-1188. doi: 10.1111/1471-0528.16238. Epub 2020 May 17. PMID: 32237069.

Beoordelingsdatum en geldigheid

Laatst beoordeeld  : 03-06-2025

Initiatief en autorisatie

Initiatief:
  • Nederlandse Vereniging voor Obstetrie en Gynaecologie
Volgende:
Counselen bij dreigende vroeggeboorte